PUBLISHER: The Business Research Company | PRODUCT CODE: 1942808
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942808
Endometrial ablation devices encompass a range of medical tools specifically engineered for conducting procedures involving the removal or destruction of the uterine lining. These devices are instrumental in addressing gynecological conditions associated with irregular uterine bleeding.
The various categories of endometrial ablation devices exist, including hysteroscopy devices, thermal balloon ablators, radiofrequency endometrial ablation devices, hydrothermal ablators, electrical ablators, and others. Hysteroscopy devices encompass a suite of medical tools employed in the diagnostic and therapeutic practice of hysteroscopy. These technologies, comprising radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon procedures, and hysteroscopic ablation, cater to diverse end-users such as ambulatory surgery centers, clinics, and hospitals.
Tariffs are influencing the endometrial ablation devices market by increasing costs of imported energy generators, catheters, electrodes, control units, and disposable components used in ablation systems. Hospitals and ambulatory surgery centers in North America and Europe are most affected due to dependence on imported medical devices, while Asia-Pacific faces higher production input costs. These tariffs are raising procedural equipment costs. However, they are also encouraging localized manufacturing, regional supplier development, and cost-optimized device innovation.
The endometrial ablation devices market research report is one of a series of new reports from The Business Research Company that provides endometrial ablation devices market statistics, including endometrial ablation devices industry global market size, regional shares, competitors with a endometrial ablation devices market share, detailed endometrial ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the endometrial ablation devices industry. This endometrial ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The endometrial ablation devices market size has grown strongly in recent years. It will grow from $3.87 billion in 2025 to $4.14 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing prevalence of abnormal uterine bleeding, expansion of gynecological care services, rising adoption of minimally invasive procedures, availability of advanced ablation technologies, growing patient awareness of treatment options.
The endometrial ablation devices market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing preference for outpatient gynecological procedures, rising adoption of next-generation ablation devices, expansion of single-use medical technologies, growing focus on faster recovery treatments, increasing investments in women's health solutions. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of radiofrequency endometrial ablation devices, growing demand for outpatient treatment options, expansion of single-use ablation technologies, enhanced focus on procedure safety and efficiency.
The rising prevalence of gynecological disorders is expected to drive the growth of the endometrial ablation devices market in the coming years. Gynecological disorders are medical conditions that affect the female reproductive system and include menstrual disorders, endometriosis, polycystic ovary syndrome (PCOS), uterine fibroids, pelvic inflammatory disease (PID), and ovarian cysts, among others. Endometrial ablation devices are used to treat these conditions by removing or destroying the uterine lining (endometrium), helping to reduce or stop heavy menstrual bleeding and manage conditions such as adenomyosis and endometrial hyperplasia. For example, in June 2023, the World Health Organization, a Switzerland-based specialized health agency dedicated to global public health, reported that PCOS affects 8-13% of women of reproductive age, with up to 70% of affected women remaining undiagnosed worldwide. Consequently, the increasing prevalence of gynecological disorders is fueling the growth of the endometrial ablation devices market.
The increasing healthcare spending is expected to drive the growth of the endometrial ablation devices market in the coming years. Healthcare expenditure refers to the total amount of financial resources allocated to healthcare services, products, and infrastructure within a specific country, region, or organization. Effective and targeted healthcare spending enhances the connectivity, safety, and overall efficiency of endometrial ablation procedures, leading to improved outcomes for women with gynecological conditions. For example, in May 2023, according to the Office for National Statistics, a UK-based government department, healthcare spending in the UK reached approximately $354.88 billion (£283 billion), representing a nominal increase of 0.7% compared to 2022. Therefore, the rising healthcare spending is driving the growth of the endometrial ablation devices market.
Key players in the endometrial ablation devices market are also working on developing advanced solutions like field ablation systems to improve efficacy and patient comfort. A field ablation system is a medical device used to treat abnormal tissue, particularly in the heart, by applying energy (such as radiofrequency, laser, or cryotherapy) to a specific area. For instance, in January 2024, Abbott Laboratories, a US-based medical device company, launched its Volt Pulsed Field Ablation (PFA) System, marking the beginning of human trials aimed at treating atrial fibrillation (AFib). This cutting-edge technology uses pulsed field energy to selectively target heart muscle cells, minimizing collateral damage to surrounding tissues compared to traditional thermal ablation techniques. The system features a balloon-in-basket catheter design for greater precision and stability, and integrates with the EnSite X cardiac mapping platform to improve procedural accuracy. Initial trials are being conducted in Australia, with plans for global expansion, positioning Abbott as a leader in AFib treatment as demand for advanced therapies grows.
Major companies operating in the endometrial ablation devices market are Hologic Inc., Medtronic plc, Boston Scientific Corporation, Olympus Corporation, The Cooper Companies Inc., Cook Medical Incorporated, Karl Storz SE & Co. KG, Richard Wolf GmbH, B. Braun Melsungen AG, Minerva Surgical Inc., AEGEA Medical Inc., Channel Medsystems Inc., Lina Medical ApS, Biolitec AG, AngioDynamics Inc., Albyn Medical Ltd., Ecleris S.R.L., Surkon Medical Co. Ltd., Omnitech Systems Inc., Veldana Medical SA
North America was the largest region in the endometrial ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endometrial ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the endometrial ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The endometrial ablation devices market consists of sales of radiofrequency ablation devices, cryoablation devices, hydrothermal devices, and microwave ablation devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Endometrial Ablation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses endometrial ablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for endometrial ablation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endometrial ablation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.